Iteos Therapeutics Inc (ITOS)

09:12 AM

iTeos Therapeutics Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional

09:12 AM

Jul 22, 2025

Assessing the Fairness of iTeos Therapeutics' $10.047-per-Share Acquisition Offer: A Valuation Deep Dive - AInvest

Jul 22, 2025

Jul 22, 2025

ITEOS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc.ITOS - The Globe and Mail

Jul 22, 2025

Jul 22, 2025

Is iTeos Therapeutics Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

iTeos Therapeutics accepts takeover bid from Concentra - The Pharma Letter

Jul 22, 2025

Jul 22, 2025

Concentra buys beleaguered iTeos at slight discount - PharmaLive

Jul 22, 2025

Jul 22, 2025

iTeos Therapeutics stock price target lowered to $10 at Leerink Partners - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

What analysts say about iTeos Therapeutics Inc. stockMassive profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives iTeos Therapeutics Inc. stock priceFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

iTeos Therapeutics (NASDAQ:ITOS) Given Outperform Rating at Wedbush - Defense World

Jul 22, 2025

Jul 21, 2025

Securities Law Risks in Biotech M&A: A Closer Look at iTeos Therapeutics' Proposed Acquisition - AInvest

Jul 21, 2025

Jul 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.

Jul 21, 2025

Jul 21, 2025

Rowley Law PLLC Investigates iTeos Therapeutics Acquisition for Securities Law Violations - AInvest

Jul 21, 2025

Jul 21, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of ITeos Therapeutics, Inc. - 富途牛牛

Jul 21, 2025

Jul 21, 2025

Navigating ITOS Stock: ITeos Therapeutics Inc Journey - investchronicle.com

Jul 21, 2025

Jul 21, 2025

iTeos Therapeutics To Be Acquired by Concentra Biosciences - citybiz

Jul 21, 2025

Jul 21, 2025

ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders - The Globe and Mail

Jul 21, 2025

Jul 21, 2025

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan

Jul 21, 2025

Jul 21, 2025

Concentra To Acquire ITeos - Nasdaq

Jul 21, 2025

Jul 21, 2025

The Strategic Rationale and Valuation Implications of Concentra Biosciences' Acquisition of iTeos Therapeutics - AInvest

Jul 21, 2025

Jul 21, 2025

iTeos Therapeutics, Inc. Enters Merger Agreement with Concentra Biosciences, LLC for $10.047 per Share Acquisition - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

iTeos Therapeutics Enters into Agreement to Be Acquired by - GlobeNewswire

Jul 21, 2025

Jul 19, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - Informazione.it

Jul 19, 2025

Jul 18, 2025

What risks could impact iTeos Therapeutics Inc. stock performanceFree Stock Index Interpretation - Newser

Jul 18, 2025

Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025

Jul 17, 2025

GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment - TipRanks

Jul 17, 2025

Jul 17, 2025

How iTeos Therapeutics Inc. stock performs during market volatilityFree Stock Market Expert Consultation - Newser

Jul 17, 2025

Jul 15, 2025

What makes iTeos Therapeutics Inc. stock price move sharplyStrategic High Profit Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

Why iTeos Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Query - Newser

Jul 15, 2025

Jul 15, 2025

GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab - TipRanks

Jul 15, 2025

Jul 09, 2025

iTeos Therapeutics (ITOS): An Example of Biotech Liquidations - MSN

Jul 09, 2025

Jul 07, 2025

iTeos Therapeutics Stock Jumps Following Operational Closure Announcement - MSN

Jul 07, 2025

Jul 06, 2025

(ITOS) Technical Data - news.stocktradersdaily.com

Jul 06, 2025

Jul 06, 2025

iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock By Investing.com - Investing.com Nigeria

Jul 06, 2025

Jul 03, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Jul 03, 2025

Jun 25, 2025

Exchange Traded Concepts LLC Acquires 3,468 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 25, 2025